Irlanda - inglese - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd, - trimethoprim - oral suspension - 50 mg/5ml

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

berk pharmaceuticals limited - trimethoprim - tablets - 20 milligram

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd, - trimethoprim - tablets - 100 milligram

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd, - trimethoprim - tablets - 200 milligram

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - trimethoprim - oral tablet - 100mg

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - trimethoprim - oral tablet - 200mg

Canada - inglese - Health Canada

whitehall-robins inc. - magaldrate; dimethicone - suspension - 96mg; 4mg - magaldrate 96mg; dimethicone 4mg - antacids and adsorbents

Bahrein - inglese - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

bahrain pharmacy - magaldrate, simethicone - oral suspension

Stati Uniti - inglese - NLM (National Library of Medicine)

physicians total care, inc. - oxybutynin chloride (unii: l9f3d9renq) (oxybutynin - unii:k9p6mc7092) - oxybutynin chloride 5 mg - ditropan xl® (oxybutynin chloride) is a once-daily controlled-release tablet indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. ditropan xl® is also indicated in the treatment of pediatric patients aged 6 years and older with symptoms of detrusor overactivity associated with a neurological condition (e.g., spina bifida). ditropan xl® (oxybutynin chloride) is contraindicated in patients with urinary retention, gastric retention and other severe decreased gastrointestinal motility conditions, uncontrolled narrow-angle glaucoma and in patients who are at risk for these conditions. ditropan xl® is also contraindicated in patients who have demonstrated hypersensitivity to the drug substance or other components of the product.

Stati Uniti - inglese - NLM (National Library of Medicine)

janssen pharmaceuticals, inc. - oxybutynin chloride (unii: l9f3d9renq) (oxybutynin - unii:k9p6mc7092) - oxybutynin chloride 5 mg - ditropan xl ® (oxybutynin chloride) is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. ditropan xl ® is also indicated for the treatment of pediatric patients aged 6 years and older with symptoms of detrusor overactivity associated with a neurological condition (e.g., spina bifida). ditropan xl ® is contraindicated in patients with urinary retention, gastric retention and other severe decreased gastrointestinal motility conditions, uncontrolled narrow-angle glaucoma. ditropan xl ® is also contraindicated in patients who have demonstrated hypersensitivity to the drug substance or other components of the product. there have been reports of hypersensitivity reactions, including anaphylaxis and angioedema. risk summary there are no adequate data on ditropan xl ® use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscar